Total Payments
$8,144
2022 Payments
$356.90
Companies
12
Transactions
57
Medicare Patients
183
Medicare Billing
$24,017
Payment Breakdown by Category
Food & Beverage$3,777 (46.4%)
Consulting$3,500 (43.0%)
Travel$867.07 (10.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,777 | 54 | 46.4% |
| Consulting Fee | $3,500 | 1 | 43.0% |
| Travel and Lodging | $867.07 | 2 | 10.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AMAG Pharmaceuticals, Inc. | $4,593 | 9 | $0 (2019) |
| Allergan, Inc. | $2,361 | 34 | $0 (2022) |
| Amgen Inc. | $241.54 | 2 | $0 (2019) |
| Merz North America, Inc. | $147.37 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $123.96 | 1 | $0 (2018) |
| Medtronic Vascular, Inc. | $123.66 | 1 | $0 (2018) |
| IBSA Pharma Inc. | $110.31 | 1 | $0 (2022) |
| Daiichi Sankyo Inc. | $99.65 | 1 | $0 (2019) |
| Galderma Laboratories, L.P. | $95.00 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $93.99 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $356.90 | 6 | Merz North America, Inc. ($147.37) |
| 2021 | $285.06 | 4 | Allergan, Inc. ($285.06) |
| 2020 | $48.65 | 2 | GlaxoSmithKline, LLC. ($48.65) |
| 2019 | $5,517 | 24 | AMAG Pharmaceuticals, Inc. ($4,593) |
| 2018 | $1,015 | 10 | Allergan Inc. ($672.79) |
| 2017 | $920.17 | 11 | Allergan Inc. ($736.06) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/13/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $41.58 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/13/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $34.02 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/13/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | Cash or cash equivalent | $23.62 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/26/2022 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $139.70 | General |
| 05/26/2022 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $7.67 | General |
| 04/20/2022 | IBSA Pharma Inc. | Tirosint (Drug) | Food and Beverage | In-kind items and services | $110.31 | General |
| Category: Endocrinology | ||||||
| 11/08/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/01/2021 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $73.18 | General |
| 10/01/2021 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $43.82 | General |
| 10/01/2021 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $43.06 | General |
| 10/21/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: VACCINES | ||||||
| 08/11/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: VACCINES | ||||||
| 12/19/2019 | Allergan, Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $10.72 | General |
| 11/19/2019 | Allergan, Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $1.12 | General |
| 10/08/2019 | Allergan Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $124.18 | General |
| 08/20/2019 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $128.85 | General |
| 08/07/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: VACCINES | ||||||
| 07/30/2019 | AMAG Pharmaceuticals, Inc. | VYLEESI (Drug) | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: HYPOACTIVE SEXUAL DESIRE DISORDER HSDD | ||||||
| 07/19/2019 | AMAG Pharmaceuticals, Inc. | VYLEESI (Drug) | Food and Beverage | In-kind items and services | $43.48 | General |
| Category: HYPOACTIVE SEXUAL DESIRE DISORDER HSDD | ||||||
| 07/19/2019 | AMAG Pharmaceuticals, Inc. | VYLEESI (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: HYPOACTIVE SEXUAL DESIRE DISORDER HSDD | ||||||
| 07/19/2019 | AMAG Pharmaceuticals, Inc. | VYLEESI (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: HYPOACTIVE SEXUAL DESIRE DISORDER HSDD | ||||||
| 07/19/2019 | AMAG Pharmaceuticals, Inc. | VYLEESI (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: HYPOACTIVE SEXUAL DESIRE DISORDER HSDD | ||||||
| 07/19/2019 | AMAG Pharmaceuticals, Inc. | VYLEESI (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: HYPOACTIVE SEXUAL DESIRE DISORDER HSDD | ||||||
| 07/18/2019 | AMAG Pharmaceuticals, Inc. | VYLEESI (Drug) | Travel and Lodging | In-kind items and services | $619.60 | General |
| Category: HYPOACTIVE SEXUAL DESIRE DISORDER HSDD | ||||||
| 07/18/2019 | AMAG Pharmaceuticals, Inc. | VYLEESI (Drug) | Travel and Lodging | In-kind items and services | $247.47 | General |
| Category: HYPOACTIVE SEXUAL DESIRE DISORDER HSDD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 96 | 137 | $49,850 | $11,909 |
| 2022 | 2 | 41 | 71 | $20,325 | $6,280 |
| 2021 | 2 | 32 | 47 | $10,155 | $4,501 |
| 2020 | 1 | 14 | 17 | $4,080 | $1,326 |
Total Patients
183
Total Services
272
Medicare Billing
$24,017
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 46 | $16,100 | $4,794 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 53 | $13,250 | $3,850 | 29.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $16,500 | $3,088 | 18.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 16 | $4,000 | $177.24 | 4.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 36 | $11,830 | $3,873 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 35 | $8,495 | $2,407 | 28.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 32 | $7,680 | $3,379 | 44.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 15 | $2,475 | $1,121 | 45.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 17 | $4,080 | $1,326 | 32.5% |
About Dr. Ann Mai, MD
Dr. Ann Mai, MD is a Internal Medicine healthcare provider based in Irvine, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215001904.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ann Mai, MD has received a total of $8,144 in payments from pharmaceutical and medical device companies, with $356.90 received in 2022. These payments were reported across 57 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($3,777).
As a Medicare-enrolled provider, Mai has provided services to 183 Medicare beneficiaries, totaling 272 services with total Medicare billing of $24,017. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Irvine, CA
- Active Since 11/17/2006
- Last Updated 08/20/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215001904
Products in Payments
- VYLEESI (Drug) $4,593
- KYBELLA (Biological) $363.28
- Aimovig (Biological) $241.54
- BOTOX (Biological) $224.22
- BOTOX COSMETIC (Biological) $223.76
- XARELTO (Drug) $123.96
- Amplia MRI (Device) $123.66
- Tirosint (Drug) $110.31
- INJECTAFER (Drug) $99.65
- FEVIPIPRANT (Drug) $93.99
- SHINGRIX (Biological) $48.65
- BEXSERO (Biological) $15.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Irvine
Dr. Tung Ngo, Do, DO
Internal Medicine — Payments: $4.9M
Internal Medicine $4.9M
Rashmi Kumar, Md, MD
Internal Medicine — Payments: $121,958
Internal Medicine $121,958
Dr. Irene Kang, M.d, M.D
Internal Medicine — Payments: $55,000
Internal Medicine $55,000
Dr. Behdad Akbarpour, Md, MD
Internal Medicine — Payments: $34,097
Internal Medicine $34,097
Dr. Maher Kassis, M.d, M.D
Internal Medicine — Payments: $30,310
Internal Medicine $30,310
Dr. Shanta Chawla, Md, MD
Internal Medicine — Payments: $17,484
Internal Medicine $17,484